QR-koodi

Magnetic hyperthermia therapy enhances the chemoradiosensitivity of glioblastoma

Abstract Glioblastoma (GBM) is the most common primary brain cancer and is resistant to standard-of-care chemoradiation therapy (CRT). Magnetic hyperthermia therapy (MHT) exposes magnetic iron oxide nanoparticles (MIONPs) to an alternating magnetic field (AMF) to generate local hyperthermia. This st...

Täydet tiedot

Tallennettuna:
Päätekijät: Daniel Rivera, Alexandros Bouras, Milena Mattioli, Maria Anastasiadou, Anna Chiara Pacentra, Olivia Pelcher, Corrine Koziel, Alexander J. Schupper, Tori Chanenchuk, Hayden Carlton, Robert Ivkov, Constantinos G. Hadjipanayis
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Portfolio 2025-03-01
Sarja:Scientific Reports
Aiheet:
Glioblastoma
Magnetic hyperthermia therapy
Magnetic iron-oxide nanoparticles
Radiation therapy
Temozolomide
Chemoradiation
Linkit:https://doi.org/10.1038/s41598-025-95544-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia